- Andrew Connor, registrar in renal medicine1,
- Lucy Sykes, senior house officer in renal medicine1,
- Ian S D Roberts, consultant histopathologist2,
- Charles E Weston, consultant nephrologist1
- 1Department of Renal Medicine, Dorset County Hospital, Dorchester DT1 2JY
- 2Department of Cellular Pathology, John Radcliffe Hospital, Oxford OX3 9DU
- Correspondence to: A Connor, 3 Hope Terrace, Martinstown, Dorset DT2 9JN andrewconnor1974{at}hotmail.co.uk
- Accepted 25 March 2008
Oral sodium phosphate preparations are used as bowel purgatives before colonoscopy. Subsequent renal impairment is increasingly being reported.1 We describe a case of acute phosphate nephropathy with persistent renal impairment after administration of sodium phosphate.
Case report
A 76 year old woman was admitted with rectal bleeding. Her past medical history included hypertension—treated with nifedipine—and long standing use of tobacco. Physical examination was unremarkable.
Laboratory results were normal—haemoglobin 106 g/l, white cell count 7.2×109/l, platelets 357×109/l, sodium 132 mmol/l, potassium 4.3 mmol/l, urea 6.2 mmol/l, and creatinine 98 µmol/l.
She underwent flexible sigmoidoscopy after being given a sodium phosphate enema (Fleet Ready-to-use; De Witt) the night before (day 1). Colonoscopy was performed on day 4 after she took two sachets of oral sodium phosphate solution (Fleet Phospho-soda; De Witt). Histological findings were consistent with chronic active ulcerative colitis. She was discharged and prescribed mesalazine.
On day 6 she presented with acute renal failure (creatinine 541 µmol/l). She received intravenous fluids and mesalazine was replaced by prednisolone enemas. A renal consultation was obtained.
Urinalysis was unremarkable. She was normocalcaemic (2.4 mmol/l) but mildly hyperphosphataemic (1.54 mmol/l). Results of a screen for glomerulonephritis and renal tract ultrasonography were normal. Interstitial nephritis secondary to mesalazine was considered and she underwent renal biopsy.
Twenty seven glomeruli were …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
The decline in the breast cancer incidence is 1.2% and it is not significant.
Published 10 February 2012
'twas ever thus
Published 10 February 2012
The value of historic human remains
Published 10 February 2012
In Praise of British Literature
Published 10 February 2012
Is real shared decision making possible?
Published 10 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (7 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012
Search for evidence goes on (5 responses)
Published 17 Jan 2012